Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Blood transfusion for stem cell company?

Nature (2008)Cite this article

Red blood cells could provide new hope for beleaguered ACT

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lu, S. et al. Blood doi:10.1182/blood-2008-05-157198 (2008).

Download references

Authors
  1. Meredith Wadman
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Nature Reports Stem Cells

Biotechnology@nature.com

Related external links

Advanced Cell Technology

Blood

Share price of ACT (ticker symbol ACTC)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wadman , M. Blood transfusion for stem cell company?. Nature (2008). https://doi.org/10.1038/news.2008.1060

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news.2008.1060

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing